Business
Bio Spectrum
AstraZeneca makes third investment of Rs 176 crore in India
AstraZeneca, a global, science-led, patient-focused pharmaceutical company dedicated to accelerating the delivery of life-changing medicines, has announced a strategic investment of Rs 176 crore, the third such investment in the past two years in India.
1 min |
October 2025
Bio Spectrum
Reveal HealthTech secures $7.2 M to power next wave of AI-driven healthcare
Reveal HealthTech, a startup with operations in India and the US, has announced its $7.2 million Series A round led by Leo Capital with participation from Sanos Capital.
1 min |
October 2025
Bio Spectrum
Botanic Healthcare invests over Rs 25 Cr in liposomal manufacturing facility in Hyderabad
Botanic Healthcare, a global leader in natural ingredients and nutraceutical innovation, has launched its dedicated Liposomal Manufacturing Facility in Hyderabad with an investment of over Rs 25 crore.
1 min |
October 2025
Bio Spectrum
"India is Shaping the Future of Global Life Sciences"
The Life Sciences industry in India is experiencing a remarkable surge, driven by a growing emphasis on precision medicine, biotechnology, and advanced diagnostics. We're seeing increased investment in research infrastructure, talent development, and innovation hubs across the country. At HORIBA, we're proud to support this momentum by providing analytical solutions that empower scientists, clinicians, and manufacturers to push boundaries and deliver meaningful outcomes.
4 min |
October 2025
Bio Spectrum
India joins HealthAI Global Regulatory Network to strengthen oversight of AI in healthcare
HealthAI - The Global Agency for Responsible AI in Health, has welcomed India as a pioneer country joining the HealthAI Global Regulatory Network (GRN), a global network of health regulators dedicated to the safe and effective use of artificial intelligence (AI) in healthcare.
1 min |
October 2025
Bio Spectrum
Health Ministry to amend New Drugs and Clinical Trials Rules 2019
In accordance with the directions of Prime Minister Narendra Modi towards reducing the regulatory compliance and towards promoting ease of doing business in the pharmaceutical and clinical research sectors, the Union Health Ministry is set to amend the New Drugs and Clinical Trials.
1 min |
October 2025
Bio Spectrum
Qiagen secures European CE-IVDR certification for Full QIAstat-Dx Portfolio
Qiagen has achieved CE-IVDR certification for its full portfolio of QIAstat-Dx syndromic testing systems and panels, including an expanded Meningitis/Encephalitis (ME) Panel that sets a new benchmark in the diagnosis of central nervous system (CNS) infections.
1 min |
October 2025
Bio Spectrum
The Science Behind Peak Athletic Performance
Focusing on how the body works during physical exercise and how sport and physical activity encourage physical, social, and mental health, the concept of sports science and technology is garnering more attention than ever across the world.
2 min |
October 2025
Bio Spectrum
Edwards Lifesciences launches next-gen transcatheter heart valve platform in India
US-based Edwards Lifesciences, a global leader in structural heart innovations, has announced the launch of its next-generation transcatheter heart valve platform in India, marking a significant milestone in the treatment of aortic stenosis.
1 min |
October 2025
Bio Spectrum
ICMR licenses nine breakthrough health technologies to industry partners
In a landmark moment for India's healthcare innovation ecosystem, the Indian Council of Medical Research (ICMR) has licensed nine cutting-edge technologies to industry partners under its Medical Innovations- Patent Mitra initiative.
1 min |
October 2025
Bio Spectrum
Laborate Pharma to Increase international revenue by $100 M over next 5 years
Laborate Pharmaceuticals, one of India's leading pharmaceutical manufacturing and export companies, is currently in advanced discussions with partners in the EU and UK for the co-development and commercial supply of finished formulations, with projected international revenue growth of over $100 million over the next five years.
1 min |
October 2025
Bio Spectrum
“Despite high disease burden, there are no national screening guidelines for multiple myeloma in India”
France-headquartered Sebia, a global leader in specialty diagnostics, is continuing its geographic footprint to better serve its customers.
5 min |
October 2025
Bio Spectrum
Navigating the Complexities of Pharma Packaging Sustainability
Pharma companies in India are increasingly adopting sustainable methods in packaging to ensure that medicines remain safe and the environment is protected. Various initiatives by the government, focusing on reducing carbon footprints, are revolutionising the pharma packaging industry.
8 min |
September 2025
Bio Spectrum
Are BioStartUps in a Funding/Innovation Rut?
At the BioStartUps Founders & Investors Forum 2025, held on August 1, 2025 at the CIDCO Exhibition Centre in Vashi, Navi Mumbai, biotech industry stalwarts deliberated on the country's innovation and startup ecosystem.
10 min |
September 2025
Bio Spectrum
How Do Recent Deaths Impact Gene Therapy Development?
Cell and gene therapy (CGT) is among the most closely watched areas in pharma and biotech.
4 min |
September 2025
Bio Spectrum
HealthQuad appoints Namit Chugh as Director
Quadria Group, Asia's leading healthcare-focused private equity platform, has announced the appointment of Namit Chugh as Director at HealthQuad, India's leading healthcare-focused growth venture capital platform.
1 min |
September 2025
Bio Spectrum
Why Is Endoscopy Crucial for Gl Cancer Diagnosis?
The increased demand for gastrointestinal (GI) diagnostics in India, driven by rising disease rates and awareness of early intervention, is not evenly distributed. While major urban hospitals have expanded their endoscopic capabilities, many semi-urban and rural areas face limited access. Addressing this disparity is crucial for extending the benefits of early disease detection across the country.
4 min |
September 2025
Bio Spectrum
New England Biolabs launches NEBNext low-bias small RNA library prep kit
US-based New England Biolabs (NEB) has announced the launch of the NEBNext Low-bias Small RNA Library Prep Kit, designed to minimise biased representation of small RNA species in sequencing data.
1 min |
September 2025
Bio Spectrum
Qiagen expands NGS portfolio with launch of QIAseq XHYB long read panels
Qiagen has announced the launch of its new QIAseq xHYB Long Read Panels, a suite of target enrichment solutions designed to unlock long-read sequencing of genomically complex regions.
1 min |
September 2025
Bio Spectrum
"Awareness and consistent training are needed with the growing demand for effective skin treatments in India"
India’s dermatology and aesthetic market is reportedly among the fastest-growing globally, projected to grow at a CAGR of 10.11 per cent from 2025 to 2032.
4 min |
September 2025
Bio Spectrum
Dr. Moopen's Legacy Scholarship & Fellowships to aid 25 students from across India
In a path breaking initiative to make medical education accessible to meritorious students and students from economically challenged backgrounds, Padma Shri Dr Azad Moopen, Founder & Chairman of Aster DM Healthcare and a globally recognised philanthropist, has announced an annual scholarship programme Dr. Moopen's Legacy Scholarship & Fellowships Programme aimed at supporting meritorious students seeking admissions in Dr. Moopen's Medical College, Dr Moopen's Nursing College and Dr Moopen's College of Pharmacy in Wayanad, Kerala.
1 min |
September 2025
Bio Spectrum
Iberia Pharma set to open manufacturing unit in India with investment of Rs 70 Cr
Gurugram-based Iberia Pharmaceuticals has announced its new hi-tech manufacturing and research facility spread across 60,000 sq. ft. in Jhajjar, Haryana.
1 min |
September 2025
Bio Spectrum
"Shortage of professionals with expertise in both AI and life sciences complicates adoption"
With its ability to both generate insights and act on them autonomously, agentic AI is poised to revolutionise the process of developing new therapies and bringing them to the market.
5 min |
September 2025
Bio Spectrum
Al/loT-Driven Real-time Cardiac Event Prediction & Treatment
It is anticipated that between 2025 and 2050, a significant 50.2 per cent increase in cardiovascular mortality rates will result in 35.6 million cardiovascular deaths by 2050, of which ischemic heart disease or coronary heart disease will remain the leading cause, accounting for 56.2 per cent of fatalities in 2050.
2 min |
September 2025
Bio Spectrum
SCHOTT announces launch of syringe and cartridge glass tubing in India
SCHOTT, a global pioneer in specialty glass, has announced the addition of syringe and cartridge glass tubing to its existing state-ofthe-art manufacturing capabilities in Jambusar, Gujarat.
1 min |
September 2025
Bio Spectrum
ICMR expands collaborative partnership with CEPI for vaccine research
Norway-based Coalition for Epidemic Preparedness Innovations (CEPI) and the Indian Council of Medical Research (ICMR) have expanded their collaborative partnership through a newly signed Memorandum of Understanding (MOU).
1 min |
September 2025
Bio Spectrum
AMTZ to open India's first advanced 3D printing hub for orthopaedic implants
In a landmark collaboration that spans three continents, OIC International (USA), Medi Mold, part of the Andhra Pradesh Medtech Zone (AMTZ) (India), and AddUp, a subsidiary of Fives Group (France) have announced a strategic partnership to establish India's most advanced orthopaedic implant manufacturing facility powered by 3D printing and precision engineering.
1 min |
September 2025
Bio Spectrum
Driving Research Continuity in Indian R&D through Remote Lab Operations
India's research landscape is undergoing rapid transformation as institutions look toward hybrid and remote working models to enhance flexibility and collaboration. By turning to cloudbased lab systems and AI-powered analytics, R&D organisations can build agile, future-ready environments to help power India's academic and industrial sectors.
4 min |
September 2025
Bio Spectrum
Alveolus Bio secures strategic investment from Shilpa Medicare
Alveolus Bio, a US-based respiratory drug development biotech company founded by Dr Vivek Lal from University of Alabama at Birmingham, has announced a strategic financing round led by Raichur-based Shilpa Medicare, a prominent global pharmaceutical company with extensive expertise in respiratory therapeutics manufacturing and biotechnology innovation.
1 min |
September 2025
Bio Spectrum
JNCASR explores potential cure for Alzheimer's Disease
Researchers from Bengaluru-based Jawaharlal Nehru Centre for Advanced Scientific Research (JNCASR), an autonomous institute of the Department of Science and Technology (DST) have explored altered miRNAs in the Alzheimer's Disease (AD) brain and also probed the potential of miRNAs to be biomarkers for early, specific and accurate clinical diagnosis of AD.
1 min |